ALGN vs. CVS: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at ALGN and CVS, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
CVS’s market capitalization of 79.73 billion USD is significantly greater than ALGN’s 12.87 billion USD, highlighting its more substantial market valuation.
ALGN’s beta of 1.68 points to significantly higher volatility compared to CVS (beta: 0.60), suggesting ALGN has greater potential for both gains and losses relative to market movements.
| Symbol | ALGN | CVS |
|---|---|---|
| Company Name | Align Technology, Inc. | CVS Health Corporation |
| Country | US | US |
| Sector | Healthcare | Healthcare |
| Industry | Medical - Devices | Medical - Healthcare Plans |
| CEO | Mr. Joseph M. Hogan | Mr. J. David Joyner CEBS |
| Price | 177.5 USD | 63.03 USD |
| Market Cap | 12.87 billion USD | 79.73 billion USD |
| Beta | 1.68 | 0.60 |
| Exchange | NASDAQ | NYSE |
| IPO Date | January 30, 2001 | November 20, 1996 |
| ADR | No | No |
Performance Comparison
This chart compares the performance of ALGN and CVS over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Data is adjusted for dividends and splits.
- ALGN: $7142.34 (-28.58%)
- CVS: $10961.81 (9.62%)
Valuation Metrics Comparison
For a detailed comparison of valuation metrics between ALGN and CVS, please refer to the table below.
| Symbol | ALGN | CVS |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 31.88 | 15.05 |
| Forward PEG Ratio (TTM) | 3.01 | 1.30 |
| Price-to-Sales Ratio (P/S, TTM) | 3.23 | 0.21 |
| Price-to-Book Ratio (P/B, TTM) | 3.44 | 1.03 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 20.40 | 13.42 |
| EV-to-EBITDA (TTM) | 15.06 | 10.18 |
| EV-to-Sales (TTM) | 3.04 | 0.40 |
| EV-to-Free Cash Flow (TTM) | 19.20 | 25.39 |
Dividend Comparison
ALGN currently offers no dividend yield, suggesting it may be reinvesting available cash back into the business for future growth, while CVS provides a 4.22% dividend yield, offering investors a component of income return.
| Symbol | ALGN | CVS |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 4.22% |
Financial Strength Metrics Comparison
This section evaluates the financial strength of ALGN and CVS. Noteworthy observations on their financial resilience, considered from an industry perspective, are detailed in the points that follow.
- CVS’s current ratio of 0.82 falls into the low category. This can indicate potential stress on the company's ability to address its short-term liabilities, suggesting that its liquid assets may not provide a strong safety margin over its immediate financial commitments, possibly impacting its operational flexibility.
| Symbol | ALGN | CVS |
|---|---|---|
| Current Ratio (TTM) | 1.21 | 0.82 |
| Quick Ratio (TTM) | 1.08 | 0.63 |
| Debt-to-Equity Ratio (TTM) | 0.03 | 1.06 |
| Interest Coverage Ratio (TTM) | -- | 3.18 |